- Home
- Industry Reports
- Healthcare
- Medical Devices
- Global In-Vitro Diagnostics Market – Size, Outlook, Trends and Forecast (2024 – 2032)
In-Vitro diagnostics is an indispensable tool in clinical practice for diagnosing and monitoring of diseases with samples originated from human specimens including blood or tissues etc., as well as providing the predicting treatment response. Rapid in-vitro diagnosis testing allows individuals to identify the disease in early stages, instead of advanced-stage therapies which are associated with increased usage of the healthcare resources. The benefits concerning in-vitro diagnostics include improved patient outcome, reduced healthcare spending, protecting consumer safety, more efficient and others.
Global In-Vitro Diagnostics Market Size & Growth:
The Global In-Vitro Diagnostics Market size is projected to reach approximately $ XX Billion by the end of 2024 with a CAGR close to X% from $XX Billion in 2018 during the forecast timeline 2018-2024. The Key factors that drive the growth of the market include increasing adoption of point-of-care testing, growing number of private diagnostic centres, increasing government expenditure on healthcare, rising incidence of chronic lifestyles & infectious diseases, growing adoption of new technologies and others. Major restraints for the In-Vitro Diagnostics include rising healthcare costs, unclear reimbursement policies, stringent regularity policies and others.
Innovations and developments in in-vitro diagnostics allow the individuals to perform pregnancy tests easily from home by placing urine samples on test sticks. These tests are accurate, less time consuming and cost-efficient. Increase in incidence of chronic diseases and rising investments for the advancement of healthcare sector by the government along with growing number of public and private diagnostic centres are key factors driving the market growth of in-vitro diagnostics market.
Global In-Vitro Diagnostics Market Share:
Various parameters divided the Global In-Vitro Diagnostics market. By the Technology, they are divided into immunodiagnostics, clinical chemistry, molecular diagnostics, haematology, clinical microbiology, coagulation & hemostasis and other technologies. As the immunodiagnostics segment was again categorised into the rapid test, western blot, radioimmunoassay, and others. The clinical chemistry segment was again categorised into the liver panel, electrolyte panel, thyroid function panel, basic metabolic panel, and others. The molecular diagnostics segment was again categorised into microarray, hybridisation, DNA sequencing, and others. Among them, Immunodiagnostics has the largest market share owing to the increasing demand for personalised medicines and growth in ageing population along with changes in demographics & lifestyles.
By product & Service, they are divided into instruments, reagents & kits, services and data management software. Among them, Reagents & Kits segment has accounted for largest market share and is also expected to be the fastest growing market during the forecast period owing to rising number of IVD tests performed and its increased accessibility towards wide-range of reagents.
By the Application, they are divided into cardiology, infectious diseases, diabetes, oncology/cancer, autoimmune diseases, HIV/AIDS, drug testing and other applications. Among them, infectious diseases have the largest market share owing to rise in the incidences of various disorders such as tuberculosis, hepatitis, and hospital-acquired infections fueled the demand for IVD techniques whereas oncology/cancer segment is expected to register highest CAGR during the forecast period owing to the growing incidence of cancer form that simulates the early detection of the disease.
By the End-User, they are divided into hospitals, point-of-care testing, laboratories, academic institutions, patient self-testing and others. Among them, laboratories have the largest market share owing to unavailability of complex tests in hospitals and commercial clinics.
By Geography, North America has the largest market share owing to the rising prevalence of chronic lifestyle and increasing acceptance of personalised medicine along with growing adoption of technologically advanced products in that region. Asia-Pacific is expected to have fastest market growth owing to improving infrastructure and growing economies in countries such as India & China.
Global In-Vitro Diagnostics Market Trends:
- DxONE has invented an automated end-to-end software solution which increases operational efficiency by automatically recording, tracking and monitoring the laboratories consumables.
- Companion Diagnostics has the potential to enable the selection of the correct drug dose at the appropriate time of a patient’s treatment course thereby reducing the overall therapy cost
Global In-Vitro Diagnostics Market Research Reports:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Abbott Laboratories, INC
- Biomerieux SA
- Beckton, Dickinson, and Company
- Bio-Rad Laboratories, INC
- Alere, INC
Along with these companies, there were many other companies considered/cited in the report while analysing the Global In-Vitro Diagnostics market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Growing number of Private Diagnostic Centres
4.1.2 Increasing Government expenditures on Healthcare
4.1.3 Raising incidence of chronic lifestyles and infectious diseases
4.1.4 Increasing adoption of point-of-care testing
4.2 Restraints
4.2.1 Raising Healthcare costs
4.2.2 Stringent Regularity Policies
4.3 Opportunities
4.3.1 Growing incidence of companion diagnostics.
4.3.2 Convergence of New Technologies.
4.4 Challenges
4.4.1 Stringent regularity framework
4.4.2 Barriers to use of these diagnostic tests
Chapter 5 Global In-Vitro Diagnostics Market – By Product & Service
5.1 Instruments
5.2 Reagents & Kits
5.3 Services
5.4 Data Management Software
5.5 Others
Chapter 6 Global In-Vitro Diagnostics Market – By Technology
6.1 Immunodiagnostics
6.1.1 Rapid Test
6.1.2 Western Bolt
6.1.3 Radioimmunoassay
6.1.4 Others
6.2 Clinical Chemistry
6.2.1 Liver Panel
6.2.2 Electrolyte Panel
6.2.3 Basic Metabolic Panel
6.2.4 Thyroid Functional Panel
6.2.5 Others
6.3 Molecular Diagnostics
6.3.1 Hybridization
6.3.2 Microarray
6.3.3 DNA Sequencing & Next Generation Sequencing
6.3.4 Other Molecular Diagnostics Technologies
6.4 Haematology
6.5 Clinical Microbiology
6.6 Coagulation & Hemostasis
6.7 Others
Chapter 7 Global In-Vitro Diagnostics Market – By Application
7.1 Cardiology
7.2 Infectious Diseases
7.3 Diabetics
7.4 Oncology/Cancer
7.5 Autoimmune Diseases
7.6 HIV/AIDS
7.7 Drug Testing
7.8 Others
Chapter 8 Global In-Vitro Diagnostics Market – By End-User
8.1 Hospitals
8.2 Point of Care Testing
8.3 Laboratories
8.4 Academic Institution
8.5 Patient Self Testing
8.6 Other End-User’s
Chapter 9 Global In-Vitro Diagnostics Market – By Geography
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 U.K.
9.3.2 Germany
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6. Rest of Europe
9.4 APAC
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Australia & New Zealand
9.4.6 Rest of APAC
9.5 South America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Others
9.6 Middle East & Africa
9.6.1 Middle East
9.6.2 Africa
Chapter 10 Global In-Vitro Diagnostics Market – Company Profiles
10.1 Abbott Laboratories, INC
10.2 Beckton, Dickinson and Company
10.3 Biomerieux SA
10.4 Bio-Rad Laboratories, INC
10.5 Danaher Corporation
10.6 Roche Diagnostics
10.7 Alere, INC
10.8 Bayer AG
10.9 Arkray
10.10 Grifols
10.11 Hologic
10.12 Illumina
10.13 Luminex
10.14 Quest Diagnostics
10.15 Quidel
Chapter 11 Global In-Vitro Diagnostics Market – Competitive Landscape
11.1. Market Share Analysis
11.2. Strategies Adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 12 Market Insights
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,528.33 - €7,584.98
- INR: ₹225,496.39 - ₹676,489.18
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,164.96 - £6,494.87
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
In-Vitro diagnostics is an indispensable tool in clinical practice for diagnosing and monitoring of diseases with samples originated from human specimens including blood or tissues etc., as well as providing the predicting treatment response. Rapid in-vitro diagnosis testing allows individuals to identify the disease in early stages, instead of advanced-stage therapies which are associated with increased usage of the healthcare resources. The benefits concerning in-vitro diagnostics include improved patient outcome, reduced healthcare spending, protecting consumer safety, more efficient and others.
Global In-Vitro Diagnostics Market Size & Growth:
The Global In-Vitro Diagnostics Market size is projected to reach approximately $ XX Billion by the end of 2024 with a CAGR close to X% from $XX Billion in 2018 during the forecast timeline 2018-2024. The Key factors that drive the growth of the market include increasing adoption of point-of-care testing, growing number of private diagnostic centres, increasing government expenditure on healthcare, rising incidence of chronic lifestyles & infectious diseases, growing adoption of new technologies and others. Major restraints for the In-Vitro Diagnostics include rising healthcare costs, unclear reimbursement policies, stringent regularity policies and others.
Innovations and developments in in-vitro diagnostics allow the individuals to perform pregnancy tests easily from home by placing urine samples on test sticks. These tests are accurate, less time consuming and cost-efficient. Increase in incidence of chronic diseases and rising investments for the advancement of healthcare sector by the government along with growing number of public and private diagnostic centres are key factors driving the market growth of in-vitro diagnostics market.
Global In-Vitro Diagnostics Market Share:
Various parameters divided the Global In-Vitro Diagnostics market. By the Technology, they are divided into immunodiagnostics, clinical chemistry, molecular diagnostics, haematology, clinical microbiology, coagulation & hemostasis and other technologies. As the immunodiagnostics segment was again categorised into the rapid test, western blot, radioimmunoassay, and others. The clinical chemistry segment was again categorised into the liver panel, electrolyte panel, thyroid function panel, basic metabolic panel, and others. The molecular diagnostics segment was again categorised into microarray, hybridisation, DNA sequencing, and others. Among them, Immunodiagnostics has the largest market share owing to the increasing demand for personalised medicines and growth in ageing population along with changes in demographics & lifestyles.
By product & Service, they are divided into instruments, reagents & kits, services and data management software. Among them, Reagents & Kits segment has accounted for largest market share and is also expected to be the fastest growing market during the forecast period owing to rising number of IVD tests performed and its increased accessibility towards wide-range of reagents.
By the Application, they are divided into cardiology, infectious diseases, diabetes, oncology/cancer, autoimmune diseases, HIV/AIDS, drug testing and other applications. Among them, infectious diseases have the largest market share owing to rise in the incidences of various disorders such as tuberculosis, hepatitis, and hospital-acquired infections fueled the demand for IVD techniques whereas oncology/cancer segment is expected to register highest CAGR during the forecast period owing to the growing incidence of cancer form that simulates the early detection of the disease.
By the End-User, they are divided into hospitals, point-of-care testing, laboratories, academic institutions, patient self-testing and others. Among them, laboratories have the largest market share owing to unavailability of complex tests in hospitals and commercial clinics.
By Geography, North America has the largest market share owing to the rising prevalence of chronic lifestyle and increasing acceptance of personalised medicine along with growing adoption of technologically advanced products in that region. Asia-Pacific is expected to have fastest market growth owing to improving infrastructure and growing economies in countries such as India & China.
Global In-Vitro Diagnostics Market Trends:
- DxONE has invented an automated end-to-end software solution which increases operational efficiency by automatically recording, tracking and monitoring the laboratories consumables.
- Companion Diagnostics has the potential to enable the selection of the correct drug dose at the appropriate time of a patient’s treatment course thereby reducing the overall therapy cost
Global In-Vitro Diagnostics Market Research Reports:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Abbott Laboratories, INC
- Biomerieux SA
- Beckton, Dickinson, and Company
- Bio-Rad Laboratories, INC
- Alere, INC
Along with these companies, there were many other companies considered/cited in the report while analysing the Global In-Vitro Diagnostics market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Growing number of Private Diagnostic Centres
4.1.2 Increasing Government expenditures on Healthcare
4.1.3 Raising incidence of chronic lifestyles and infectious diseases
4.1.4 Increasing adoption of point-of-care testing
4.2 Restraints
4.2.1 Raising Healthcare costs
4.2.2 Stringent Regularity Policies
4.3 Opportunities
4.3.1 Growing incidence of companion diagnostics.
4.3.2 Convergence of New Technologies.
4.4 Challenges
4.4.1 Stringent regularity framework
4.4.2 Barriers to use of these diagnostic tests
Chapter 5 Global In-Vitro Diagnostics Market – By Product & Service
5.1 Instruments
5.2 Reagents & Kits
5.3 Services
5.4 Data Management Software
5.5 Others
Chapter 6 Global In-Vitro Diagnostics Market – By Technology
6.1 Immunodiagnostics
6.1.1 Rapid Test
6.1.2 Western Bolt
6.1.3 Radioimmunoassay
6.1.4 Others
6.2 Clinical Chemistry
6.2.1 Liver Panel
6.2.2 Electrolyte Panel
6.2.3 Basic Metabolic Panel
6.2.4 Thyroid Functional Panel
6.2.5 Others
6.3 Molecular Diagnostics
6.3.1 Hybridization
6.3.2 Microarray
6.3.3 DNA Sequencing & Next Generation Sequencing
6.3.4 Other Molecular Diagnostics Technologies
6.4 Haematology
6.5 Clinical Microbiology
6.6 Coagulation & Hemostasis
6.7 Others
Chapter 7 Global In-Vitro Diagnostics Market – By Application
7.1 Cardiology
7.2 Infectious Diseases
7.3 Diabetics
7.4 Oncology/Cancer
7.5 Autoimmune Diseases
7.6 HIV/AIDS
7.7 Drug Testing
7.8 Others
Chapter 8 Global In-Vitro Diagnostics Market – By End-User
8.1 Hospitals
8.2 Point of Care Testing
8.3 Laboratories
8.4 Academic Institution
8.5 Patient Self Testing
8.6 Other End-User’s
Chapter 9 Global In-Vitro Diagnostics Market – By Geography
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 U.K.
9.3.2 Germany
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6. Rest of Europe
9.4 APAC
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Australia & New Zealand
9.4.6 Rest of APAC
9.5 South America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Others
9.6 Middle East & Africa
9.6.1 Middle East
9.6.2 Africa
Chapter 10 Global In-Vitro Diagnostics Market – Company Profiles
10.1 Abbott Laboratories, INC
10.2 Beckton, Dickinson and Company
10.3 Biomerieux SA
10.4 Bio-Rad Laboratories, INC
10.5 Danaher Corporation
10.6 Roche Diagnostics
10.7 Alere, INC
10.8 Bayer AG
10.9 Arkray
10.10 Grifols
10.11 Hologic
10.12 Illumina
10.13 Luminex
10.14 Quest Diagnostics
10.15 Quidel
Chapter 11 Global In-Vitro Diagnostics Market – Competitive Landscape
11.1. Market Share Analysis
11.2. Strategies Adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 12 Market Insights
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.